- August-December
- 05
- 2021-2040
Prosigna webinar
Learn more about Prosigna, the only test providing intrinsic molecular subtypes based on PAM50 gene signature that more comprehensively informs treatment decisions.
Veracyte
Veracyte develops actionable genomic tests to inform diagnosis and treatment decisions in thyroid cancer, lung cancer, breast cancer and idiopathic pulmonary fibrosis. Hear from your peers how they are integrating these tests into clinical practice.